Journal of Molecular Medicine

, Volume 91, Issue 2, pp 157–164

Adenosine and gastrointestinal inflammation

Authors

    • Department of Medicine and the Mucosal Inflammation ProgramUniversity of Colorado School of Medicine
  • Blair Fennimore
    • Department of Medicine and the Mucosal Inflammation ProgramUniversity of Colorado School of Medicine
  • Stefan F. Ehrentraut
    • Department of Medicine and the Mucosal Inflammation ProgramUniversity of Colorado School of Medicine
Review

DOI: 10.1007/s00109-012-0990-0

Cite this article as:
Colgan, S.P., Fennimore, B. & Ehrentraut, S.F. J Mol Med (2013) 91: 157. doi:10.1007/s00109-012-0990-0

Abstract

Nucleosides such as adenosine (Ado) influence nearly every aspect of physiology and pathophysiology. Extracellular nucleotides liberated at local sites of inflammation are metabolized through regulated phosphohydrolysis by a series of ecto-nucleotidases including ectonucleoside triphosphate diphosphohydrolase-1 (CD39) and ecto-5′-nucleotidase (CD73), found on the surface of a variety of cell types. Once generated, Ado is made available to bind and activate one of four G protein-coupled Ado receptors. Recent in vitro and in vivo studies implicate Ado in a broad array of tissue-protective mechanisms that provide new insight into adenosine actions. Studies in cultured cells and murine tissues have indicated that Ado receptors couple to novel posttranslational protein modifications, including Cullin deneddylation, as a new anti-inflammatory mechanism. Studies in Ado receptor-null mice have been revealing and indicate a particularly important role for the Ado A2B receptor in animal models of intestinal inflammation. Here, we review contributions of Ado to cell and tissue stress responses, with a particular emphasis on the gastrointestinal mucosa.

Keywords

MucosaInflammationColitisNeutrophilEpitheliumEndotheliumMurine model

Copyright information

© Springer-Verlag Berlin Heidelberg 2013